GeneDx Holdings Corp. (WGSWW NASDAQ) stock market data APIs
$0.0503
0.01(19.9%)
as of July 11, 2025
Try our APIs with
free plan!
GeneDx Holdings Corp. Financial Data Overview
Price chart is built with
Anychart
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
Prev. Close
0.0503
Open
0.0589
High
0.0589
Low
0.0401
52 wk Range
0.022-0.341
Market Cap
0
Revenue
330 M
Beta
2.01
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GeneDx Holdings Corp. data using free add-ons & libraries
Get GeneDx Holdings Corp. Fundamental Data
GeneDx Holdings Corp. Fundamental data includes:
- Net Revenue: 330 M
- EBITDA: 9 083 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GeneDx Holdings Corp. News
New
GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025
GAITHERSBURG, Md., July 10, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for...
Lyft And 2 Additional Stocks Believed To Be Trading Below Fair Value
The United States market has experienced a notable increase, climbing 1.9% in the last week and rising 12% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In...
GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics
--Data demonstrates that rapid genomic testing dropped the average time to a precise genetic diagnosis from almost ten months to 13 days --Despite broad utilization in the study, rapid genomic sequen...
GeneDx Holdings Corp.'s (NASDAQ:WGS) Profit Outlook
GeneDx Holdings Corp. (NASDAQ:WGS) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. GeneDx Holdings Corp., a genomics company, provides...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
